S100A12 and ganglioneuroma: The conducted statistical analyses revealed a significant difference in the serum profiles of pro-GN, PTX3 and S100A12 between patients with Crohn’s disease and healthy individuals, indicating the diagnostic usefulness of all the analyzed biomarkers in this disease.